Matches in Nanopublications for { ?s ?p "[The solid-phase was either recombinant hepatitis B core antigen (rHBcAg) or rHBcAg converted to HBeAg by addition of 0.1% SDS with remaining HBcAg antigenicity blocked with monoclonal anti-HBc.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 2 of
2
with 100 items per page.
- NP294958.RAusjwOzoCE123DLLJYYbPrfGnJ1WG3MNgMR3OeWJW4qA130_assertion description "[The solid-phase was either recombinant hepatitis B core antigen (rHBcAg) or rHBcAg converted to HBeAg by addition of 0.1% SDS with remaining HBcAg antigenicity blocked with monoclonal anti-HBc.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP294958.RAusjwOzoCE123DLLJYYbPrfGnJ1WG3MNgMR3OeWJW4qA130_provenance.
- NP509740.RAOdxp9snvhJUxBucj7qq924d_QeHyeeJJl65KJPNibQ8130_assertion description "[The solid-phase was either recombinant hepatitis B core antigen (rHBcAg) or rHBcAg converted to HBeAg by addition of 0.1% SDS with remaining HBcAg antigenicity blocked with monoclonal anti-HBc.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP509740.RAOdxp9snvhJUxBucj7qq924d_QeHyeeJJl65KJPNibQ8130_provenance.